The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 10 November 2003 doi:10.1084/jem.20031152
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sitnicka, E.
Right arrow Articles by Jacobsen, S. E. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sitnicka, E.
Right arrow Articles by Jacobsen, S. E. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© Rockefeller University Press, 0022-1007/2003/11/1495 $5.00
The Journal of Experimental Medicine, Volume 198, Number 10, 1495-1506

Complementary Signaling through flt3 and Interleukin-7 Receptor {alpha} Is Indispensable for Fetal and Adult B Cell Genesis

Ewa Sitnicka1, Cord Brakebusch2, Inga-Lill Martensson3, Marcus Svensson4, William W. Agace4, Mikael Sigvardsson1, Natalija Buza-Vidas1, David Bryder1, Corrado M.Cilio5, Henrik Ahlenius1, Eugene Maraskovsky6, Jacques J. Peschon7 and Sten Eirik W. Jacobsen1

1 Hematopoietic Stem Cell Laboratory, Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University Hospital, SE-221 84 Lund, Sweden
2 Max Planck Institute of Biochemistry, 82152 Martinsried, Germany
3 Developmental Immunology, Babraham Institute, CB2 4AT Cambridge, UK
4 Immunology Section, Department of Cell and Molecular Biology, University of Lund, 221 00 Lund, Sweden
5 Department of Paediatrics and Department of Endocrinology, Malmö University Hospital, SE 205 02 Malmö, Sweden
6 Ludwig Institute for Cancer Research, Heidelberg, Victoria, 3084, Australia
7 Amgen Corporation, Seattle, WA 98101

Address correspondence to Sten Eirik W. Jacobsen, Hematopoietic Stem Cell Laboratory, Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University Hospital, BMC 10, Klinikgatan 26, 221-84 Lund, Sweden. Phone: 46-46-2224852; Fax: 46-46-2223600; email: Sten.Jacobsen{at}stemcell.lu.se

Extensive studies of mice deficient in one or several cytokine receptors have failed to support an indispensable role of cytokines in development of multiple blood cell lineages. Whereas B1 B cells and Igs are sustained at normal levels throughout life of mice deficient in IL-7, IL-7R{alpha}, common cytokine receptor gamma chain, or flt3 ligand (FL), we report here that adult mice double deficient in IL-7R{alpha} and FL completely lack visible LNs, conventional IgM+ B cells, IgA+ plasma cells, and B1 cells, and consequently produce no Igs. All stages of committed B cell progenitors are undetectable in FL-/- x IL-7R{alpha}-/- BM that also lacks expression of the B cell commitment factor Pax5 and its direct target genes. Furthermore, in contrast to IL-7R{alpha}-/- mice, FL-/- x IL-7R{alpha}-/- mice also lack mature B cells and detectable committed B cell progenitors during fetal development. Thus, signaling through the cytokine tyrosine kinase receptor flt3 and IL-7R{alpha} are indispensable for fetal and adult B cell development.

Key Words: lymphopoiesis • IL-7 receptor • Flt3 ligand • Pax5 • B1 cells


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS